Very very interesting... Too bad CYDY has beat them to the punch. Now they will only get a licensing deal instead of big percentage of the company. Thats how I would do this. They didn't help with any of the research, just because they are bigger, they should not be able to buy it out right. Especially with the Cancer aspect of this. CYDY is "The Little Red Hen!"